Sema4 has appointed Gustavo Stolovitzky, PhD, to the newly established senior leadership position of Chief Science Officer.
Dr. Stolovitzky is a world-renowned expert in computational biology, disease modeling and nano-biotechnology, with over 25 years of experience in high throughput data analysis for biology and the application of technology to solve biomedical problems